Technical / White Paper

The Impact of Contraceptive Requirements on Pediatric Clinical Trials

Published

Format: PDF file | Document type: Technical / White Paper

The Impact of Contraceptive Requirements on Pediatric Clinical Trials

Related categories: Phase I-II, Phase III-IV, Regulatory affairs

PRA’s whitepaper The Impact of Contraceptive Requirements on Pediatric Clinical Trials​ considers sponsors responsibilities in navigating the complex logistical and ethical considerations faced by those developing medicines for children. Download now.

Latest content from PRA Health Sciences

Promise of progress: FDA commitment to enhancing pediatric medicines

Content provided by PRA Health Sciences

Promise of progress: FDA commitment to enhancing pediatric medicines

The Commissioner of the FDA, Scott Gottlieb, recently informed a US House Committee on Appropriations of the agency’s intention to expand its guidance documents on developing drugs in specific disease areas to increase the number of new medicines in these...

Supplier info centre